EMPIGET LT 25/5 TABS 28’

EMPIGET LT Tablets 25mg + 5mg (28’s pack) combine Empagliflozin and Linagliptin to provide comprehensive management of type 2 diabetes mellitus. Each tablet contains 25mg of Empagliflozin, an SGLT2 inhibitor that helps eliminate excess glucose through the kidneys, and 5mg of Linagliptin, a DPP-4 inhibitor that enhances insulin secretion and reduces glucagon levels.

This dual-action formula supports effective blood glucose control, assists in weight management, and may lower cardiovascular risks. The 28-tablet pack offers a convenient supply for ongoing therapy.

Manufactured under stringent quality standards, EMPIGET LT Tablets ensure safety, efficacy, and consistent therapeutic benefits. Patients should follow their healthcare provider’s guidance and maintain a healthy lifestyle to maximize results.